Open AccessPapulopustular rash following Moderna COVID-19 (mRNA-1273) vaccine: A case report
Author(s) -
David Pudukadan
Publication year - 2022
Publication title -
journal of skin and sexually transmitted diseases./journal of skin and sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 2994-6026
pISSN - 2582-3175
DOI - 10.25259/jsstd_85_2021
Subject(s) - vaccination , medicine , papulopustular , rash , covid-19 , adverse effect , disease , dermatology , intensive care medicine , immunology , pediatrics , infectious disease (medical specialty) , rosacea , acne
Coronavirus disease-2019 (COVID-19) has affected countries around the world. The introduction of COVID-19 vaccines has proved the most effective arsenal in the fight against the disease. However, with the vaccination of billions of people, data on vaccine-induced adverse reactions are also emerging. We report a 32-year-old woman who manifested papulopustular rash 7 days after receiving Moderna COVID-19 (mRNA-1273) vaccine. The patient responded to a short course of systemic steroids and antihistamines. Awareness regarding the possible adverse events that can be anticipated after the COVID-19 vaccination may help the healthcare professionals to offer prompt and effective care to the affected.